# US 2012/0278911 A1 · Transgenic animal overexpressing luciferase and preparation method thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0278911 A1
- Document ID: US20120278911A1
- Status: Published application
- Kind: A1
- Application number: 13/456,400
- Filed: 2012-04-26
- Published: 2012-11-01
- Earliest claimed: 2011-04-26
- Assignees: Snu R&Db Foundation
- Inventors: Eun Young CHOI; Hye Won Youn
- Web page: https://patentgrep.com/patent/US20120278911A1

## CPC

- A01K 67/0275: Genetically modified vertebrates, e.g. transgenic
- A01K 2217/052: inducing gain of function
- A01K 2267/0393: Animal model comprising a reporter system for screening tests
- A01K: ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS

## Abstract

The present disclosure provides a vector comprising a promoter and a luciferase gene having a nucleic acid sequence as disclosed in SEQ ID NO: 1; a fertilized egg transformed with the present vector; and a transgenic non-human animal overexpressing a luciferase gene from the vector and a method for preparing it. The vector and the animal of the present disclosure have a high expression rate for the luciferase gene, which confers high sensitivity for detection and thus useful for imaging analysis in a variety of research areas.

## Claims

### Claim 1

A pCAGGSeffluc vector comprising a promoter and a luciferase gene having a nucleic acid sequence as disclosed in SEQ ID NO: 1.

### Claim 2 (depends on 1)

The vector according to claim 1, wherein the promoter is for a ubiquitous expression, a conditional expression or a tissue specific expression.

### Claim 3 (depends on 2)

The vector according to claim 2, wherein the promoter is for a ubiquitous expression.

### Claim 4 (depends on 3)

The vector according to claim 3, wherein the promoter for the ubiquitous expression is a beta-actin promoter.

### Claim 5 (depends on 4)

The vector according to claim 4, wherein the beta-actin promoter is a chicken beta-actin promoter.

### Claim 6 (depends on 1)

A fertilized egg transformed with the vector as disclosed in claim 1.

### Claim 7 (depends on 6)

The fertilized egg according to claim 6, wherein the egg is deposited with the Korean Collection for Type Cultures under the deposit No: KCTC11912BP.

### Claim 8 (depends on 1)

A transgenic non-human animal transformed with the vector as disclosed in claims 1.

### Claim 9 (depends on 8)

The transgenic animal according to claim 8, wherein the animal is produced by implanting a fertilized egg transformed with the vector to the uterine of a foster.

### Claim 10 (depends on 8)

The transgenic animal according to claim 8, wherein the animal overexpress a luciferase gene having a nucleic acid sequence as disclosed in SEQ ID NO: 1.

### Claim 11 (depends on 8)

The transgenic animal according to claim 8, wherein the animal is a mouse of C57BL/6 strain.

### Claim 12 (depends on 6)

The transgenic animal according to claim 6, wherein the C57BL/6 strain mouse is used as a research tool for studying cell development, cell differentiation, cell migration, cell proliferation, cell or organ transplant, genetics, or for immune and cancer research.

### Claim 13

A method for preparing a non-human transgenic animal overexpressing a luciferase protein comprising: preparing a vector comprising a promoter and a luciferase gene having a nucleic acid sequence as disclosed in SEQ ID NO: 1; introducing the prepared vector to a fertilized egg; and implanting the fertilized egg to the uterine tube of a foster.

### Claim 14 (depends on 13)

The method of claim 13, wherein the introduction of the vector is performed by a technique selected from a group consisting of a microinjection technique, a stem cell insertion technique, a retroviral insertion technique and sperm-mediated gene transfer technique.

### Claim 15 (depends on 13)

The method according to claim 13, wherein the animal is a mouse of C57BL/6 strain.

### Claim 16 (depends on 15)

The method according to claim 15, wherein the fertilized egg is prepared by treating a female mouse of C57BL/6 strain with a gonadotropin to induce superovulation followed by mating the female mouse with a male mouse of C57BL/6 strain.

### Claim 17 (depends on 16)

The method according to claim 16, wherein the gonadotropin is a pregnant mare's serum gonadotropin (PMSG) or human chorionic gonadotropin (HCG) or a combination thereof.
